ArticleRedox report : communications in free radical research2016

The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial.

Lei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.